Home / Blog – Mesothelioma Help Cancer Organization / Drug Combined With Immunotherapy “Thwarts Tumor Growth,” Increases Survival

Drug Combined With Immunotherapy “Thwarts Tumor Growth,” Increases Survival

Oncologists report success in some cancer patients treated with immunotherapy. However, researchers continue to search for ways to increase the effectiveness to expand the treatment to even more patients – hopefully, to more mesothelioma patients. Now, a team of researchers report that a combination treatment that blocks a protein while at the same time awakening the immune system could be the next break needed to increase survival in cancer patients. Read about another study where using a two-pronged approach to improve immunotherapy could help mesothelioma patients. Researchers at MD Anderson Cancer Center found that patients treated with ipilimumab (Yervoy), an […]

The post Drug Combined With Immunotherapy “Thwarts Tumor Growth,” Increases Survival appeared first on Mesothelioma Help Cancer Organization.



from Blog – Mesothelioma Help Cancer Organization https://ift.tt/2z16NnJ
via IFTTT
Drug Combined With Immunotherapy “Thwarts Tumor Growth,” Increases Survival Drug Combined With Immunotherapy “Thwarts Tumor Growth,” Increases Survival Reviewed by Unknown on July 02, 2018 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.